Clinical Trials in Colorado

Showing 10821-10840 of 15,592 trials

VenaSeal Sapheon Closure System Pivotal Study (VeClose)

NCT01807585

The VeClose pivotal study was a controlled, randomized, prospective, multicenter, pivotal study in which patients with venous reflux in the great saphenous vein (GSV) were treated with either the VenaSeal closure system (VenaSeal SCS) or radiofrequency ablation (RFA) therapy.

Great Saphenous Vein (GSV) With Venous Reflux Disease

Medtronic Endovascular242 participantsStarted Mar 2013

Scottsdale, Arizona, United States • San Diego, California, United States • Greenwood Village, Colorado, United States +7 more locations

COMPLETEDPhase 350 miles

Asthma Clinical Research Network (ACRN) Trial - Tiotropium Bromide as an Alternative to Increased Inhaled Corticosteroid in Patients Inadequately Controlled on a Lower Dose of Inhaled Corticosteroid (TALC)

NCT00565266

Typically, people with asthma are initially prescribed a low dose of inhaled corticosteroid (ICS) medication to control asthma symptoms. If a low dose of ICS is ineffective at controlling symptoms, the addition of a second controller medication is recommended. This study will examine the effectiveness of the medication tiotropium bromide combined with a low dose of ICS at maintaining asthma control in people with moderately severe asthma.

Asthma

Milton S. Hershey Medical Center210 participantsStarted May 2008

San Diego, California, United States • San Francisco, California, United States • Denver, Colorado, United States +7 more locations

VenaSeal Sapheon Closure System Pivotal Study (VeClose)

Asthma Clinical Research Network (ACRN) Trial - Tiotropium Bromide as an Alternative to Increased Inhaled Corticosteroid in Patients Inadequately Controlled on a Lower Dose of Inhaled Corticosteroid (TALC)

Find Trials by Condition in Colorado

Innovative Tool to Increase Completion of Human Papillomavirus (HPV) Vaccine Series

CARE Network Maintenance Versus Intermittent Inhaled Steroids in Wheezing Toddlers (MIST)

Effect of Acid Blockade on Microbiota and Inflammation in Cystic Fibrosis (CF)

Rebif® Versus Copaxone® in the Treatment of Relapsing Remitting Multiple Sclerosis

Multi-center, Randomized, Double-blind Efficacy and Safety of CD0271 0.3%/CD1579 2.5 % Topical Gel in Acne Vulgaris

Follow-up Study to Evaluate the Safety and Immunogenicity of a HPV Vaccine (580299) in North America

Study to Assess the Immune Reactivity of the Liquid and Lyophilized Formulations of Palivizumab (MEDI-493, Synagis)

A Post-approval LAP-BAND® Lower Body Mass Index (LBMI) Study

Measuring the Impact of MammaPrint on Adjuvant and Neoadjuvant Treatment in Breast Cancer Patients: A Prospective Registry

The Usability and Injection Time of the Physiolis Syringe and Autoinjector in Rheumatoid Arthritis Patients

Pivotal Study to Evaluate the Effectiveness of a Micro-coring Device Treating Moderate to Severe Facial Wrinkles

Temozolomide and Carmustine in Treating Patients With Anaplastic Glioma

Temozolomide Plus Thalidomide in Treating Patients With Recurrent or Progressive Brain Tumor

Gefitinib in Treating Patients With Recurrent or Progressive CNS Tumors

Safety and Tolerability Study of ISIS EIF4E Rx in Combination With Carboplatin and Paclitaxel

Temozolomide Plus Irinotecan in Treating Patients With Recurrent Malignant Glioma

Safety, Tolerability and Efficacy of ISIS-GCGRRx in Patients With Type 2 Diabetes

ABT-888, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme